Article Information
History
- May 2, 2021.
Article Versions
- Version 1 (February 16, 2021 - 07:19).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- aSwiss Tropical and Public Health Institute, Basel, Switzerland
- bUniversity of Basel, Basel, Switzerland
- cZeeman Institute, University of Warwick, Coventry, UK
- dMathematics Institute, University of Warwick, Coventry, UK
- ↵2To whom correspondence should be addressed. E-mail: marina.antillon{at}swisstph.ch
↵1 K.S.R. contributed equally to this work with F.T.
Posted May 02, 2021.
Economic evaluation of disease elimination: an extension to the net-benefit framework and application to human African trypanosomiasis
